经前期烦躁障碍发病机制及治疗研究进展
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R749.42

基金项目:

上海市浦东新区卫生和计划生育委员会重点专科建设项目(PWZzk2017-20).


Pathogenesis and treatment of premenstrual dysphoric disorder: research progress
Author:
Affiliation:

Fund Project:

Supported by Key Discipline Construction Program of Shanghai Pudong New Area Health and Family Planning Commission (PWZzk2017-20).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    经前期烦躁障碍(PMDD)在美国《精神障碍诊断和统计手册》第5版(DSM-5)中被列为心境障碍的一个类型,除了呈现情绪低落、烦躁等抑郁症状外,还可伴随躯体症状,具有经前期发作的特点。PMDD的病因和发病机制尚未明确,与其发病可能有关的因素包括雌性激素的波动、神经类固醇激素作用减弱、免疫激活和炎症反应、有关脑区(杏仁核、前额叶等)功能活动异常、心理社会因素等。因发病机制不明,PMDD尚未有根治性治疗方法,目前主要通过药物治疗(如抗抑郁药与口服避孕药)、心理治疗、中医药治疗(如中药、针灸)等方面缓解患者症状。

    Abstract:

    Premenstrual dysphoric disorder (PMDD) is diagnosed as a type of mood disorder in the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5). In addition to depressive symptoms, PMDD can be accompanied by somatic symptoms and is characterized by cyclicity (premenstrual). The etiology and pathogenesis of PMDD are not clear, probably involving the fluctuation of estrogen, the weakened role of neurosteroids hormones, immune activation and inflammatory response, the abnormal functional activities of some brain areas (such as amygdala, prefrontal cortex), psychosocial factors, etc. There is no radical treatment for PMDD due to the unknown pathogenesis. Treatments including drugs (such as antidepressants, oral contraceptives), psychotherapy, and complementary medicines (such as traditional Chinese medicine, acupuncture) are used to relieve patients' symptoms.

    参考文献
    相似文献
    引证文献
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-03-20
  • 最后修改日期:2021-08-28
  • 录用日期:
  • 在线发布日期: 2021-12-18
  • 出版日期:
文章二维码
重要通知
友情提醒: 近日发现论文正式见刊或网络首发后,有人冒充我刊编辑部名义给作者发邮件,要求添加微信,此系诈骗行为!可致电编辑部核实:021-81870792。
            《海军军医大学学报》编辑部
关闭